Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature
Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published c...
Gespeichert in:
| Veröffentlicht in: | Journal of neuroimmunology 2021-10, Vol.359, p.577691-577691, Article 577691 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 577691 |
|---|---|
| container_issue | |
| container_start_page | 577691 |
| container_title | Journal of neuroimmunology |
| container_volume | 359 |
| creator | Min, Young Gi Ju, Woohee Ha, Ye-Eun Ban, Jae-Jun Lee, Seol Ah Sung, Jung-Joon Shin, Je-Young |
| description | Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published cases of GBS after ChAdOx1 vaccination, highlighting their unique clinical and paraclinical features. We propose a possible association between the risk of GBS and the ChAdOx1 vaccine and recommend surveillance for GBS following vaccination. Population-based studies are needed to determine causality and whether specific subpopulations are susceptible.
[Display omitted]
•We describe two sensory Guillain-Barre syndromes (GBS) after the ChAdOx1 vaccine.•We highlight the unique features of published GBS cases after the ChAdOx1 vaccine.•We propose a possible association between the vaccine and GBS.•To determine causality, data accumulation and epidemiologic analyses are mandatory. |
| doi_str_mv | 10.1016/j.jneuroim.2021.577691 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8349403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165572821002186</els_id><sourcerecordid>S0165572821002186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-e05e188087cabf1c0f9811f8ade24772c627c33141ed6bed9bedf1e5579e93223</originalsourceid><addsrcrecordid>eNqFUV1P4zAQtBCno8D9BeQ_kJ7XcWKHBwRUfElISHfwbLn2hrpK7cpOW_rvL1UBwdM9rFbanZnVzhByBmwMDOrf8_E84CpFvxhzxmFcSVk3cEBGoCQvlOBwSEYDsCoqydUROc55zhhUpWh-kqNSCKgFsBHJfzHkmLb0buW7zvhQXJuUkOZtcCkukLax6-LGh1faz5BOZlfu6Q1omMR1AQ1dG2t9wHP6B5cx9TS2tN9Eak3GTE1wNOHa42Y373yPyfSrhKfkR2u6jL_e-wl5ub15ntwXj093D5Orx8IKCX2BrEJQiilpzbQFy9pGAbTKOORCSm5rLm1ZggB09RRdM1QLWFWywabkvDwhF3vd5Wq6QGcx9Ml0epn8wqStjsbr75vgZ_o1rrUaXBKsHATqvYBNMeeE7ScXmN7FoOf6Iwa9i0HvYxiIZ18vf9I-fB8Al3sADv8PDiWdrcdg0fmEttcu-v_d-AfDgZ-C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Min, Young Gi ; Ju, Woohee ; Ha, Ye-Eun ; Ban, Jae-Jun ; Lee, Seol Ah ; Sung, Jung-Joon ; Shin, Je-Young</creator><creatorcontrib>Min, Young Gi ; Ju, Woohee ; Ha, Ye-Eun ; Ban, Jae-Jun ; Lee, Seol Ah ; Sung, Jung-Joon ; Shin, Je-Young</creatorcontrib><description>Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published cases of GBS after ChAdOx1 vaccination, highlighting their unique clinical and paraclinical features. We propose a possible association between the risk of GBS and the ChAdOx1 vaccine and recommend surveillance for GBS following vaccination. Population-based studies are needed to determine causality and whether specific subpopulations are susceptible.
[Display omitted]
•We describe two sensory Guillain-Barre syndromes (GBS) after the ChAdOx1 vaccine.•We highlight the unique features of published GBS cases after the ChAdOx1 vaccine.•We propose a possible association between the vaccine and GBS.•To determine causality, data accumulation and epidemiologic analyses are mandatory.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/j.jneuroim.2021.577691</identifier><identifier>PMID: 34416410</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; ChAdOx1 ; ChAdOx1 nCoV-19 ; COVID-19 ; COVID-19 - prevention & control ; COVID-19 Vaccines - adverse effects ; Female ; Guillain-Barre syndrome ; Guillain-Barre Syndrome - chemically induced ; Guillain-Barre Syndrome - diagnostic imaging ; Humans ; Male ; Middle Aged ; SARS-CoV-2 ; Short Communication ; Vaccines</subject><ispartof>Journal of neuroimmunology, 2021-10, Vol.359, p.577691-577691, Article 577691</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><rights>2021 Elsevier B.V. All rights reserved. 2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-e05e188087cabf1c0f9811f8ade24772c627c33141ed6bed9bedf1e5579e93223</citedby><cites>FETCH-LOGICAL-c471t-e05e188087cabf1c0f9811f8ade24772c627c33141ed6bed9bedf1e5579e93223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jneuroim.2021.577691$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34416410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Min, Young Gi</creatorcontrib><creatorcontrib>Ju, Woohee</creatorcontrib><creatorcontrib>Ha, Ye-Eun</creatorcontrib><creatorcontrib>Ban, Jae-Jun</creatorcontrib><creatorcontrib>Lee, Seol Ah</creatorcontrib><creatorcontrib>Sung, Jung-Joon</creatorcontrib><creatorcontrib>Shin, Je-Young</creatorcontrib><title>Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature</title><title>Journal of neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published cases of GBS after ChAdOx1 vaccination, highlighting their unique clinical and paraclinical features. We propose a possible association between the risk of GBS and the ChAdOx1 vaccine and recommend surveillance for GBS following vaccination. Population-based studies are needed to determine causality and whether specific subpopulations are susceptible.
[Display omitted]
•We describe two sensory Guillain-Barre syndromes (GBS) after the ChAdOx1 vaccine.•We highlight the unique features of published GBS cases after the ChAdOx1 vaccine.•We propose a possible association between the vaccine and GBS.•To determine causality, data accumulation and epidemiologic analyses are mandatory.</description><subject>Adult</subject><subject>ChAdOx1</subject><subject>ChAdOx1 nCoV-19</subject><subject>COVID-19</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>Female</subject><subject>Guillain-Barre syndrome</subject><subject>Guillain-Barre Syndrome - chemically induced</subject><subject>Guillain-Barre Syndrome - diagnostic imaging</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>SARS-CoV-2</subject><subject>Short Communication</subject><subject>Vaccines</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUV1P4zAQtBCno8D9BeQ_kJ7XcWKHBwRUfElISHfwbLn2hrpK7cpOW_rvL1UBwdM9rFbanZnVzhByBmwMDOrf8_E84CpFvxhzxmFcSVk3cEBGoCQvlOBwSEYDsCoqydUROc55zhhUpWh-kqNSCKgFsBHJfzHkmLb0buW7zvhQXJuUkOZtcCkukLax6-LGh1faz5BOZlfu6Q1omMR1AQ1dG2t9wHP6B5cx9TS2tN9Eak3GTE1wNOHa42Y373yPyfSrhKfkR2u6jL_e-wl5ub15ntwXj093D5Orx8IKCX2BrEJQiilpzbQFy9pGAbTKOORCSm5rLm1ZggB09RRdM1QLWFWywabkvDwhF3vd5Wq6QGcx9Ml0epn8wqStjsbr75vgZ_o1rrUaXBKsHATqvYBNMeeE7ScXmN7FoOf6Iwa9i0HvYxiIZ18vf9I-fB8Al3sADv8PDiWdrcdg0fmEttcu-v_d-AfDgZ-C</recordid><startdate>20211015</startdate><enddate>20211015</enddate><creator>Min, Young Gi</creator><creator>Ju, Woohee</creator><creator>Ha, Ye-Eun</creator><creator>Ban, Jae-Jun</creator><creator>Lee, Seol Ah</creator><creator>Sung, Jung-Joon</creator><creator>Shin, Je-Young</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20211015</creationdate><title>Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature</title><author>Min, Young Gi ; Ju, Woohee ; Ha, Ye-Eun ; Ban, Jae-Jun ; Lee, Seol Ah ; Sung, Jung-Joon ; Shin, Je-Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-e05e188087cabf1c0f9811f8ade24772c627c33141ed6bed9bedf1e5579e93223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>ChAdOx1</topic><topic>ChAdOx1 nCoV-19</topic><topic>COVID-19</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>Female</topic><topic>Guillain-Barre syndrome</topic><topic>Guillain-Barre Syndrome - chemically induced</topic><topic>Guillain-Barre Syndrome - diagnostic imaging</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>SARS-CoV-2</topic><topic>Short Communication</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Min, Young Gi</creatorcontrib><creatorcontrib>Ju, Woohee</creatorcontrib><creatorcontrib>Ha, Ye-Eun</creatorcontrib><creatorcontrib>Ban, Jae-Jun</creatorcontrib><creatorcontrib>Lee, Seol Ah</creatorcontrib><creatorcontrib>Sung, Jung-Joon</creatorcontrib><creatorcontrib>Shin, Je-Young</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Min, Young Gi</au><au>Ju, Woohee</au><au>Ha, Ye-Eun</au><au>Ban, Jae-Jun</au><au>Lee, Seol Ah</au><au>Sung, Jung-Joon</au><au>Shin, Je-Young</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature</atitle><jtitle>Journal of neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2021-10-15</date><risdate>2021</risdate><volume>359</volume><spage>577691</spage><epage>577691</epage><pages>577691-577691</pages><artnum>577691</artnum><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>Massive vaccination against COVID-19 has become a global priority. Simultaneously, concerns regarding the safety of vaccines are growing. We describe two patients who developed sensory Guillain-Barre syndrome (GBS) shortly after the first dose of the ChAdOx1 vaccine. We also summarize 12 published cases of GBS after ChAdOx1 vaccination, highlighting their unique clinical and paraclinical features. We propose a possible association between the risk of GBS and the ChAdOx1 vaccine and recommend surveillance for GBS following vaccination. Population-based studies are needed to determine causality and whether specific subpopulations are susceptible.
[Display omitted]
•We describe two sensory Guillain-Barre syndromes (GBS) after the ChAdOx1 vaccine.•We highlight the unique features of published GBS cases after the ChAdOx1 vaccine.•We propose a possible association between the vaccine and GBS.•To determine causality, data accumulation and epidemiologic analyses are mandatory.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34416410</pmid><doi>10.1016/j.jneuroim.2021.577691</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0165-5728 |
| ispartof | Journal of neuroimmunology, 2021-10, Vol.359, p.577691-577691, Article 577691 |
| issn | 0165-5728 1872-8421 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8349403 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adult ChAdOx1 ChAdOx1 nCoV-19 COVID-19 COVID-19 - prevention & control COVID-19 Vaccines - adverse effects Female Guillain-Barre syndrome Guillain-Barre Syndrome - chemically induced Guillain-Barre Syndrome - diagnostic imaging Humans Male Middle Aged SARS-CoV-2 Short Communication Vaccines |
| title | Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sensory%20Guillain-Barre%20syndrome%20following%20the%20ChAdOx1%20nCov-19%20vaccine:%20Report%20of%20two%20cases%20and%20review%20of%20literature&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Min,%20Young%20Gi&rft.date=2021-10-15&rft.volume=359&rft.spage=577691&rft.epage=577691&rft.pages=577691-577691&rft.artnum=577691&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/j.jneuroim.2021.577691&rft_dat=%3Celsevier_pubme%3ES0165572821002186%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34416410&rft_els_id=S0165572821002186&rfr_iscdi=true |